MeVPMe7 (L), n=1 cell(s)

Main group: Visual Projection Neurons; Neurotransmitter consensus prediction: Glu

Mean synapse counts per layer

  LA
Post -
Pre -
  M1 M2 M3 M4 M5 M6 M7 M8 M9 M10 Total
0 - - - - 9.0 287.0 63.0 - - - 359
1 - - - - 1.0 704.0 92.0 - - - 797
  LO1 LO2 LO3 LO4 LO5a LO5b LO6 Total
Post - - - - - - - -
Pre - - - - - - - -
  AME
0 17
1 1
  LOP1 LOP2 LOP3 LOP4 Total
Post - - - - -
Pre - - - - -
  central brain
0 3
1 3

Neuron visualizations

Population spatial coverage

Medulla

Number of post synapses: 359

Number of pre synapses: 797

Number of output connections: 2509

Coverage factor: 1.0

Columnar completeness: 0.23

Area completeness: 0.56

Cell size (columns): 203

Lobula

Number of post synapses: 0

Number of pre synapses: 0

Number of output connections: 0

Coverage factor: 0

Columnar completeness: 0

Area completeness: 0

Cell size (columns): 0

Lobula Plate

Number of post synapses: 0

Number of pre synapses: 0

Number of output connections: 0

Coverage factor: 0

Columnar completeness: 0

Area completeness: 0

Cell size (columns): 0

Optic Lobe Connectivity

Inputs

  instance NT total connections connections /#MeVPMe7 (L) % % cumu.
0 Cm1 (R) ACh 66 66.0 17.8% 17.8%
1 MeVP2 (R) ACh 57 57.0 15.4% 33.2%
2 Dm8a (R) Glu 46 46.0 12.4% 45.7%
3 MeVP10 (R) ACh 31 31.0 8.4% 54.1%
4 Tm5c (R) Glu 25 25.0 6.8% 60.8%
5 Cm28 (R) unclear 15 15.0 4.1% 64.9%
6 MeVC9 (L) ACh 14 14.0 3.8% 68.6%
7 Cm9 (R) Glu 11 11.0 3.0% 71.6%
8 MeVP27 (R) unclear 10 10.0 2.7% 74.3%
9 aMe4 (R) ACh 8 8.0 2.2% 76.5%
10 MeVC5 (L) ACh 8 8.0 2.2% 78.6%
11 aMe5 (R) ACh 7 7.0 1.9% 80.5%
12 MeVP7 (R) ACh 6 6.0 1.6% 82.2%
13 Cm7 (R) Glu 4 4.0 1.1% 83.2%
14 Cm_unclear (R) ACh 4 4.0 1.1% 84.3%
15 Dm2 (R) ACh 4 4.0 1.1% 85.4%
16 Cm5 (R) GABA 3 3.0 0.8% 86.2%
17 Dm8b (R) Glu 3 3.0 0.8% 87.0%
18 MeLo4 (R) ACh 3 3.0 0.8% 87.8%
19 TmY10 (R) ACh 3 3.0 0.8% 88.6%
20 Cm2 (R) ACh 2 2.0 0.5% 89.2%
21 Cm21 (R) GABA 2 2.0 0.5% 89.7%
22 Cm31b (R) GABA 2 2.0 0.5% 90.3%
23 Cm4 (R) Glu 2 2.0 0.5% 90.8%
24 MeLo3a (R) ACh 2 2.0 0.5% 91.4%
25 MeVP21 (R) ACh 2 2.0 0.5% 91.9%
26 Mi4 (R) GABA 2 2.0 0.5% 92.4%
27 Tm5a (R) ACh 2 2.0 0.5% 93.0%
28 5-HTPMPV03 (R) 5HT 1 1.0 0.3% 93.2%
29 aMe12 (R) ACh 1 1.0 0.3% 93.5%
30 aMe17a (R) Glu 1 1.0 0.3% 93.8%
31 aMe2 (R) Glu 1 1.0 0.3% 94.1%
32 aMe22 (R) Glu 1 1.0 0.3% 94.3%
33 Cm11a (R) ACh 1 1.0 0.3% 94.6%
34 Cm26 (R) Glu 1 1.0 0.3% 94.9%
35 Cm29 (R) GABA 1 1.0 0.3% 95.1%
36 Cm3 (R) GABA 1 1.0 0.3% 95.4%
37 Cm31a (R) GABA 1 1.0 0.3% 95.7%
38 Cm32 (R) GABA 1 1.0 0.3% 95.9%
39 Cm6 (R) GABA 1 1.0 0.3% 96.2%
40 Dm9 (R) Glu 1 1.0 0.3% 96.5%
41 HBeyelet (R) His 1 1.0 0.3% 96.8%
42 MeLo7 (R) ACh 1 1.0 0.3% 97.0%
43 MeVC20 (R) Glu 1 1.0 0.3% 97.3%
44 MeVC22 (R) Glu 1 1.0 0.3% 97.6%
45 MeVC6 (L) ACh 1 1.0 0.3% 97.8%
46 MeVP40 (R) unclear 1 1.0 0.3% 98.1%
47 MeVP6_unclear (R) Glu 1 1.0 0.3% 98.4%
48 MeVPLo2 (R) ACh 1 1.0 0.3% 98.6%
49 MeVPMe13 (R) ACh 1 1.0 0.3% 98.9%
50 Mi15 (R) ACh 1 1.0 0.3% 99.2%
51 OLVC4 (L) unclear 1 1.0 0.3% 99.5%
52 Tm20 (R) ACh 1 1.0 0.3% 99.7%
53 TmY17 (R) ACh 1 1.0 0.3% 100.0%

Outputs

  instance NT total connections connections /#MeVPMe7 (L) % % cumu.
0 MeVP2 (R) ACh 485 485.0 19.3% 19.3%
1 Cm28 (R) unclear 334 334.0 13.3% 32.6%
2 Tm5c (R) Glu 213 213.0 8.5% 41.1%
3 MeVP27 (R) unclear 135 135.0 5.4% 46.4%
4 Cm11c (R) ACh 121 121.0 4.8% 51.3%
5 MeLo4 (R) ACh 120 120.0 4.8% 56.0%
6 MeVP10 (R) ACh 102 102.0 4.1% 60.1%
7 Cm9 (R) Glu 98 98.0 3.9% 64.0%
8 MeTu3b (R) ACh 89 89.0 3.5% 67.5%
9 MeTu1 (R) ACh 88 88.0 3.5% 71.0%
10 Cm31b (R) GABA 72 72.0 2.9% 73.9%
11 Cm8 (R) GABA 43 43.0 1.7% 75.6%
12 MeVP7 (R) ACh 39 39.0 1.6% 77.2%
13 Cm32 (R) GABA 33 33.0 1.3% 78.5%
14 Tm33 (R) ACh 32 32.0 1.3% 79.7%
15 Tm40 (R) ACh 31 31.0 1.2% 81.0%
16 Cm11a (R) ACh 30 30.0 1.2% 82.2%
17 Cm3 (R) GABA 29 29.0 1.2% 83.3%
18 Cm34 (R) Glu 29 29.0 1.2% 84.5%
19 aMe5 (R) ACh 24 24.0 1.0% 85.4%
20 MeVP63 (R) GABA 20 20.0 0.8% 86.2%
21 Cm6 (R) GABA 19 19.0 0.8% 87.0%
22 Pm4 (R) GABA 17 17.0 0.7% 87.7%
23 Cm11b (R) ACh 16 16.0 0.6% 88.3%
24 MeVP30 (R) ACh 16 16.0 0.6% 88.9%
25 Cm19 (R) GABA 14 14.0 0.6% 89.5%
26 Cm7 (R) Glu 14 14.0 0.6% 90.1%
27 Cm1 (R) ACh 13 13.0 0.5% 90.6%
28 Tm38 (R) ACh 13 13.0 0.5% 91.1%
29 aMe12 (R) ACh 12 12.0 0.5% 91.6%
30 MeTu4d (R) ACh 12 12.0 0.5% 92.0%
31 Tm36 (R) ACh 12 12.0 0.5% 92.5%
32 Cm31a (R) GABA 9 9.0 0.4% 92.9%
33 Cm5 (R) GABA 9 9.0 0.4% 93.2%
34 TmY18 (R) ACh 9 9.0 0.4% 93.6%
35 Cm2 (R) ACh 7 7.0 0.3% 93.9%
36 MeVP41 (R) ACh 7 7.0 0.3% 94.2%
37 MeVP8 (R) ACh 7 7.0 0.3% 94.4%
38 Tm26 (R) ACh 7 7.0 0.3% 94.7%
39 aMe10 (R) ACh 6 6.0 0.2% 94.9%
40 Cm29 (R) GABA 6 6.0 0.2% 95.2%
41 MeVP25 (R) unclear 6 6.0 0.2% 95.4%
42 MeVC22 (R) Glu 5 5.0 0.2% 95.6%
43 MeVP52 (R) ACh 5 5.0 0.2% 95.8%
44 Tm5b (R) ACh 5 5.0 0.2% 96.0%
45 Tm5Y (R) ACh 5 5.0 0.2% 96.2%
46 MeVP14 (R) ACh 4 4.0 0.2% 96.4%
47 MeVPMe3 (R) Glu 4 4.0 0.2% 96.5%
48 Cm11d (R) ACh 3 3.0 0.1% 96.7%
49 Cm15 (R) GABA 3 3.0 0.1% 96.8%
50 Cm33 (R) GABA 3 3.0 0.1% 96.9%
51 MeVP47 (R) unclear 3 3.0 0.1% 97.0%
52 Tm29 (R) Glu 3 3.0 0.1% 97.1%
53 Tm30 (R) GABA 3 3.0 0.1% 97.3%
54 Tm5a (R) ACh 3 3.0 0.1% 97.4%
55 TmY10 (R) ACh 3 3.0 0.1% 97.5%
56 5-HTPMPV03 (L) 5HT 2 2.0 0.1% 97.6%
57 5-HTPMPV03 (R) 5HT 2 2.0 0.1% 97.7%
58 Cm23 (R) Glu 2 2.0 0.1% 97.7%
59 MeTu3a (R) ACh 2 2.0 0.1% 97.8%
60 MeVP1 (R) ACh 2 2.0 0.1% 97.9%
61 MeVP3 (R) ACh 2 2.0 0.1% 98.0%
62 MeVPMe12 (R) ACh 2 2.0 0.1% 98.1%
63 Mi14 (R) Glu 2 2.0 0.1% 98.1%
64 Mi15 (R) ACh 2 2.0 0.1% 98.2%
65 Mi2 (R) Glu 2 2.0 0.1% 98.3%
66 Mi4 (R) GABA 2 2.0 0.1% 98.4%
67 OA-AL2i4 (R) OA 2 2.0 0.1% 98.4%
68 R7y (R) His 2 2.0 0.1% 98.5%
69 Tm20 (R) ACh 2 2.0 0.1% 98.6%
70 Tm37 (R) Glu 2 2.0 0.1% 98.7%
71 TmY14 (R) Glu 2 2.0 0.1% 98.8%
72 TmY5a (R) Glu 2 2.0 0.1% 98.8%
73 aMe20 (R) unclear 1 1.0 0.0% 98.9%
74 aMe9 (R) ACh 1 1.0 0.0% 98.9%
75 Cm-DRA (R) ACh 1 1.0 0.0% 99.0%
76 Cm17 (R) GABA 1 1.0 0.0% 99.0%
77 Cm21 (R) GABA 1 1.0 0.0% 99.0%
78 Cm26 (R) Glu 1 1.0 0.0% 99.1%
79 Cm35 (R) GABA 1 1.0 0.0% 99.1%
80 Dm2 (R) ACh 1 1.0 0.0% 99.2%
81 DN1a (R) unclear 1 1.0 0.0% 99.2%
82 l-LNv (R) unclear 1 1.0 0.0% 99.2%
83 Lawf1 (R) ACh 1 1.0 0.0% 99.3%
84 LoVP53 (R) ACh 1 1.0 0.0% 99.3%
85 LT88 (R) Glu 1 1.0 0.0% 99.4%
86 MeTu3c (R) ACh 1 1.0 0.0% 99.4%
87 MeVP12 (R) ACh 1 1.0 0.0% 99.4%
88 MeVP15 (R) ACh 1 1.0 0.0% 99.5%
89 MeVP36 (R) unclear 1 1.0 0.0% 99.5%
90 MeVP56 (R) unclear 1 1.0 0.0% 99.6%
91 MeVP6 (R) Glu 1 1.0 0.0% 99.6%
92 MeVPMe13 (L) ACh 1 1.0 0.0% 99.6%
93 Mi1 (R) ACh 1 1.0 0.0% 99.7%
94 Mi10 (R) ACh 1 1.0 0.0% 99.7%
95 Mi16 (R) GABA 1 1.0 0.0% 99.8%
96 Mi18 (R) GABA 1 1.0 0.0% 99.8%
97 Tm1 (R) ACh 1 1.0 0.0% 99.8%
98 Tm2 (R) ACh 1 1.0 0.0% 99.9%
99 Tm3 (R) ACh 1 1.0 0.0% 99.9%
100 Tm31 (R) Glu 1 1.0 0.0% 100.0%
101 Tm39 (R) ACh 1 1.0 0.0% 100.0%